Featured Research

from universities, journals, and other organizations

Taking aim at tumors

Date:
April 25, 2011
Source:
Binghamton University
Summary:
Many of the newest weapons in the war on cancer come in the form of personalized therapies that can target specific changes in an individual's tumor. By disrupting molecular processes in tumor cells, these drugs can keep the tumor from growing and spreading. Researchers are now deploying a new tool in their study of an enzyme called tubulin tyrosine ligase, or TTL.

Many of the newest weapons in the war on cancer come in the form of personalized therapies that can target specific changes in an individual's tumor. By disrupting molecular processes in tumor cells, these drugs can keep the tumor from growing and spreading. At the forefront of this work are Binghamton University researchers, Susan Bane, and Susannah Gal, who are deploying a new tool in their study of an enzyme called tubulin tyrosine ligase, or TTL.

In developing these targeted therapies, scientists need to understand exactly what kind of activities within a tumor cell these drugs disturb. Bane, a professor of organic and biological chemistry, and Gal, an associate professor of biological sciences, are getting an insider's look at these cells and paying particular interest to the many cancer cells that contain less-than-normal levels of TTL.

Funded by the National Institute of General Medical Sciences, Bane and Gal's work focuses on microtubules, which are structures that provide part of the scaffolding that gives a cell its structure and also help chromosomes line up correctly during cell division.

These microtubules are made of proteins called tubulin and during the course of a cell's life, an enzyme called carboxypeptidase clips an amino acid called tyrosine off the end of some of these proteins. Later, TTL puts tyrosine back on the tubulin. No one knows the purpose of this cycle, but as Bane points out, "We do know that if you don't have that enzyme, you'll die."

In certain cancer cells, the cycle of removing and reattaching tyrosine has fallen out of balance: Too many tubulins lack tyrosine.

"Patients who have that characteristic in their tumor have a poor prognosis," Bane says. "And those tumors tend to grow more aggressively."

Hoping to learn more about the role of TTL in cancer, Bane and Gal are studying the removal and reattachment of tyrosine in live cells.

Bane has developed a way to mark tubulin with a fluorescent molecule using TTL, allowing the researchers to observe tubulin in action under a fluorescent microscope. The new labeling technique, using a small molecule, provides an easier way to watch the behavior of microtubules as cells divide. Cancer cells are often undergoing cell division at a much faster rate than normal cells, making the process a major target of cancer research.

Although Bane and Gal aren't trying to develop a new cancer treatment, their efforts to learn the role of TTL in tumor growth could someday make it easier to choose a treatment for a specific case of the disease.

"Potentially, someone could send us their tumor sample, and we could put it in our labeling system and say, 'Yes, that has a problem with the TTL system, and therefore you should be more aggressive with it,'" Gal says. "Or we could say, 'That's probably OK, so you can treat it with normal chemotherapy.'"

Bane and Gal are very hopeful that this new approach will then allow clinicians to treat cancer far more effectively as therapies would be personalized to an individual's tumor.


Story Source:

The above story is based on materials provided by Binghamton University. Note: Materials may be edited for content and length.


Cite This Page:

Binghamton University. "Taking aim at tumors." ScienceDaily. ScienceDaily, 25 April 2011. <www.sciencedaily.com/releases/2011/04/110419121351.htm>.
Binghamton University. (2011, April 25). Taking aim at tumors. ScienceDaily. Retrieved October 23, 2014 from www.sciencedaily.com/releases/2011/04/110419121351.htm
Binghamton University. "Taking aim at tumors." ScienceDaily. www.sciencedaily.com/releases/2011/04/110419121351.htm (accessed October 23, 2014).

Share This



More Health & Medicine News

Thursday, October 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Working Mother (Oct. 22, 2014) Is your child ready? Video provided by Working Mother
Powered by NewsLook.com
U.S. Issues Ebola Travel Restrictions, Are Visa Bans Next?

U.S. Issues Ebola Travel Restrictions, Are Visa Bans Next?

Newsy (Oct. 22, 2014) Now that the U.S. is restricting travel from West Africa, some are dropping questions about a travel ban and instead asking about visa bans. Video provided by Newsy
Powered by NewsLook.com
US to Track Everyone Coming from Ebola Nations

US to Track Everyone Coming from Ebola Nations

AP (Oct. 22, 2014) Stepping up their vigilance against Ebola, federal authorities said Wednesday that everyone traveling into the US from Ebola-stricken nations will be monitored for symptoms for 21 days. (Oct. 22) Video provided by AP
Powered by NewsLook.com
Doctors Help Paralysed Man Walk Again, Patient in Disbelief

Doctors Help Paralysed Man Walk Again, Patient in Disbelief

AFP (Oct. 22, 2014) Polish doctors describe how they helped a paralysed man walk again, with the patient in disbelief at the return of sensation to his legs. Duration: 1:04 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins